A new PanCAN-authored paper uses feedback provided by patients with pancreatic cancer to identify trends in reporting pain.

As part of our strategic approach to improve outcomes for pancreatic cancer patients, our Scientific and Medical Affairs team conducts independent and collaborative research. We disseminate important ...

Pancreatic cancer patients who participate in clinical research have better outcomes. Learn more and search our up-to-date clinical trials database.

Guiding the Pancreatic Cancer Community - Pancreatic Cancer Action Network*PanCAN’s Case Managers are not medical or nutritional professionals and are therefore unable to provide medical/nutritional ...

The Pancreatic Cancer Action Network (PanCAN), the leading nonprofit organization dedicated to [...] READ MORE ...

Learn about the common symptoms of the world’s toughest cancer, such as weight loss, digestive problems, back pain and more.

American Cancer Society’s Cancer Facts & Figures 2023 reports that the five-year survival rate for pancreatic cancer has increased to 12%, progress that PanCAN’s initiatives helped to fuel.

About 20 percent of patients are eligible for surgery at diagnosis. Learn more about the types of surgery, such as the Whipple, and the importance of molecularly profiling the tumor tissue.

For the first time in more than 10 years, the FDA has approved a new first-line treatment, called NALIRIFOX, for patients with metastatic pancreatic cancer.

Learn why jaundice, which causes a yellowing of the skin and eyes, can be a symptom of pancreatic cancer.

For the third year in the row, the pancreatic cancer five-year survival rate has increased one percentage point, to 13%, according to the American Cancer Society’s Cancer Facts & Figures 2024 Report.